Click to view graph
Connections
Click to view timeline
Timeline
Projects
Publications
Download-
2023Functional and structural insights into the multi-step activation and catalytic mechanism of bacterial ExoY nucleotidyl cyclase toxins bound to actin-profilin, PLoS Pathogens, 2023, 19 (9), pp.e1011654. ⟨10.1371/journal.ppat.1011654⟩.
-
2021Mechanism of actin-dependent activation of nucleotidyl cyclase toxins from bacterial human pathogens., Nat Commun 2021 11; 12(1): 6628.
-
2018Differential regulation of actin-activated nucleotidyl cyclase virulence factors by filamentous and globular actin, PLoS ONE 2018;13(11):e0206133.
-
2018The extreme C terminus of the effector ExoY is crucial for binding to its eukaryotic activator, F-actin, J. Biol. Chem. 2018 12;293(51):19785-19796.
-
2017ExoY, an actin-activated nucleotidyl cyclase toxin from P. aeruginosa: A minireview, Toxicon 2018 Jul;149:65-71.
-
2016Actin activates Pseudomonas aeruginosa ExoY nucleotidyl cyclase toxin and ExoY-like effector domains from MARTX toxins, Nat Commun 2016 Dec;7:13582.
-
2015Oligoribonuclease is a central feature of cyclic diguanylate signaling in Pseudomonas aeruginosa, Proc. Natl. Acad. Sci. U.S.A. 2015 Aug;.
-
2014Two-step synthesis and hydrolysis of cyclic di-AMP in Mycobacterium tuberculosis, PLoS ONE 2014;9(1):e86096.
-
2013Differential regulation by ppGpp versus pppGpp in Escherichia coli, Nucleic Acids Res. 2013 Jul;41(12):6175-89.
-
20123′-5′ phosphoadenosine phosphate is an inhibitor of PARP-1 and a potential mediator of the lithium-dependent inhibition of PARP-1 in vivo, Biochem. J. 2012 Apr;443(2):485-90.
-
+View full list of publications